IVDR (In Vitro Diagnostic Regulation)

IVDR (In Vitro Diagnostic Regulation) - Axcellant

IVDR (In Vitro Diagnostic Regulation)

  1. lut 28, 2025

What Does the 'IVDR (In Vitro Diagnostic Regulation)’ Mean?

IVDR stands for In Vitro Diagnostic Regulation, which is a set of rules governing in vitro diagnostic medical devices in the European Union. This regulation aims to ensure the safety and performance of diagnostic tests used outside the human body, such as blood tests, urine analysis, and genetic screening.

The IVDR establishes a new regulatory framework for manufacturers, importers, and distributors of in vitro diagnostic devices. It introduces stricter requirements for clinical evidence, post-market surveillance, and traceability of devices throughout the supply chain, enhancing patient safety and healthcare quality.

Why Is the 'IVDR (In Vitro Diagnostic Regulation)’ Important in Clinical Research?

IVDR is crucial in clinical research as it directly impacts the development, validation, and use of diagnostic tests in clinical trials. It ensures that in vitro diagnostic devices used in research meet high standards of quality and reliability, which is essential for generating accurate and trustworthy clinical data.

Understanding IVDR is important for researchers and sponsors to navigate regulatory compliance and market access for new diagnostic technologies. It influences study design, data collection methods, and the overall conduct of clinical investigations involving in vitro diagnostic devices, particularly in the European Union.

Good Practices and Procedures

  1. Implement a risk-based classification system for in vitro diagnostic devices, ensuring appropriate conformity assessment procedures are followed for each risk class
  2. Establish a comprehensive post-market surveillance plan, including proactive data collection and analysis to continuously monitor device performance and safety
  3. Develop and maintain a Quality Management System (QMS) that integrates IVDR requirements with existing ISO 13485 standards for medical devices
  4. Create a Unique Device Identification (UDI) system for all IVD products to enhance traceability and facilitate efficient product recalls if necessary
  5. Conduct periodic internal audits to assess compliance with IVDR requirements and implement corrective actions as needed

Related Terms

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…